Obesity drugs give Danish economy a major boost
Massive demand for diabetes and weight loss drugs made by Danish pharmaceutical group Novo Nordisk have turned it into Europe's most valuable company, giving Denmark's economy a major makeover."If it wasn't for Novo Nordisk there wouldn't have been any growth" in the first six months of the year, Danske Bank chief economist Las Olsen told AFP. The company's earnings have ballooned thanks to two in-demand prescription medications: type 2 diabetes drug Ozempic -- made famous by US celebrities for